March 3, 2026Open Access

Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries

Key Points

This study highlights the transferability of real world evidence to enhance treatment decisions for rare diseases.
Key findings indicate that the TTE method shows promise in addressing health technology assessment challenges.
Observational analysis reveals five main conclusions regarding the novelty and application of the TTE method in healthcare.
Implications suggest that optimizing real world evidence could significantly influence health outcomes in lower income settings.

Abstract

This is the first study to explore how RWE generated by the TTE method can be transferred to optimize treatment decisions of patients with a rare disease in countries with limited HTA capacities. Five general concluding statements were made on the novelty of the TTE method and on how to overcome main challenges of transferring TTE results to HTA systems in LIECs.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Kaló et al. (Tue,) studied this question.

synapsesocial.com/papers/69a75b10c6e9836116a21aeb https://doi.org/https://doi.org/10.1002/hsr2.71534

Bookmark

View Full Paper